Reason for request
Inscription
Mise à disposition d'un générique d'Orfadin.
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par NITISINONE MENDELIKABS 2 mg, 5mg et 10 mg, gélules est important dans l’indication de l’AMM.
|
Clinical Added Value
| no clinical added value |
Ces spécialités n’apportent pas d’amélioration du service médical rendu (ASMR V) par rapport aux princeps ORFADIN 2 mg, 5 mg et 10 mg, gélules.
|
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
tzV4kXCvyx0Vkgx4